Walleye Trading
ATRA icon

Walleye Trading’s Atara Biotherapeutics ATRA Stock Holding History

Walleye Trading’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,024
Closed -$503K – 4784
2020
Q4 		$503K Buy
+1,024
New +$473K ﹤0.01% 2652
2020
Q1 		– Sell
-200
Closed -$82K – 3965
2019
Q4 		$82K Sell
200
-228
-53% -$78.6K ﹤0.01% 3641
2019
Q3 		$151K Buy
428
+80
+23% +$29.9K ﹤0.01% 3102
2019
Q2 		$175K Buy
+348
New +$246K ﹤0.01% 3031

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Walleye Trading's ATRA Position: Q1 2021 in Review

Walleye Trading sold out of Atara Biotherapeutics (ATRA) in Q1 2021, closing a stake of 421 shares — an estimated $207K sold.

Walleye Trading first reported a position in ATRA in Q2 2017 and held it in 5 quarters. The position peaked at $207K in Q4 2020. 151 funds tracked by Wall St. Rank hold ATRA as of Q1 2021.

  • Walleye Trading reported no remaining Atara Biotherapeutics position as of Q1 2021 after selling out during the quarter.
  • Walleye Trading sold 421 Atara Biotherapeutics shares in Q1 2021, an estimated $207K.
  • Walleye Trading first reported a position in Atara Biotherapeutics in Q2 2017 and held it in 5 quarters.
  • Walleye Trading's Atara Biotherapeutics position peaked at $207K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2021.

Based on Walleye Trading's 13F filing for Q1 2021, filed 17 May 2021.